Emerging treatments for primary sclerosing cholangitis
Author:
Affiliation:
1. Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, USA
2. College of Health Solutions, Arizona State University, Phoenix, AZ, USA
Publisher
Informa UK Limited
Subject
Gastroenterology,Hepatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/17474124.2017.1293524
Reference97 articles.
1. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
2. New Therapeutic Strategies for Primary Sclerosing Cholangitis
3. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis
4. Liver Transplantation in Primary Sclerosing Cholangitis
5. Diagnosis and management of primary sclerosing cholangitis
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fecal Microbiota Transplantation in Diseases Not Associated with Clostridium difficile: Current Status and Future Therapeutic Option;Microbiome in 3P Medicine Strategies;2023
2. The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease;PLOS ONE;2022-11-15
3. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation;Medicina;2022-01-06
4. Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases;The FASEB Journal;2021-09-02
5. The role of complement activation in autoimmune liver disease;Autoimmunity Reviews;2020-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3